CTRI Number |
CTRI/2020/05/024994 [Registered on: 04/05/2020] Trial Registered Prospectively |
Last Modified On: |
02/05/2020 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Preventive Behavioral |
Study Design |
Randomized, Parallel Group Trial |
Public Title of Study
|
Assessment of post operative pain after Total Lparoscopic Hysterectomy |
Scientific Title of Study
|
Assessment of Vaginal Vault infiltration by Bupivacaine for postoperative pain after Total Laparoscopic Hysterectomy : ARandomized Control Trial . |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
KALLOL KUMAR ROY |
Designation |
PROFESSOR DEPARTMENT OF OBSTETRICS AND GYNAECOLOGY |
Affiliation |
ALL INDIA INSTITUTE OF MEDICAL SCIENCES |
Address |
ALL INDIA INSTITUTE OF MEDICAL SCIENCES
Room no 3085 3rd floor
Department of Obstetrics and Gynaecology
Ansari Nagar New Delhi
110029
New Delhi DELHI 110029 India |
Phone |
|
Fax |
|
Email |
drkkroy2003@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
KALLOL KUMAR ROY |
Designation |
PROFESSOR DEPARTMENT OF OBSTETRICS AND GYNAECOLOGY |
Affiliation |
ALL INDIA INSTITUTE OF MEDICAL SCIENCES |
Address |
ALL INDIA INSTITUTE OF MEDICAL SCIENCES
Room number 3085, third floor
Department of Obstetrics and Gynaecology
Ansari nagar, New Delhi
110029
New Delhi DELHI 110029 India |
Phone |
|
Fax |
|
Email |
drkkroy2003@gmail.com |
|
Details of Contact Person Public Query
|
Name |
KANIKARAM POOJITHA KALYANI |
Designation |
JUNIOR RESIDENT DEPARTMENT OF OBSTETRICS AND GYNAECOLOGY |
Affiliation |
ALL INDIA INSTITUTE OF MEDICAL SCINECES |
Address |
ALL INDIA INSTITUTE OF MEDICAL SCIENCES
Room number 3085, third floor
Department of Obstetrics and Gynaecology
Ansari Nagar New Delhi
110029
New Delhi DELHI 110029 India |
Phone |
|
Fax |
|
Email |
kpooji@gmail.com |
|
Source of Monetary or Material Support
|
Department of Obstetrics and Gynaecology
All India Institute Of Medical Sciences New Delhi |
|
Primary Sponsor
|
Name |
Department of Obstetrics and Gynaecology |
Address |
All India Institute Of Medical Sciences
Ansari nagar, New Delhi.
110029 |
Type of Sponsor |
Government medical college |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Kanikaram Poojitha Kalyani |
ALL INDIA INSTITUTE OF MEDICAL SCIENCES |
All India Institute of medical Sciences
room no 3085,third floor
Department of Obstetrics and Gynaecology
Ansari nagar New Delhi
110029 New Delhi DELHI |
9717468813
kpooji@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
INSTITUTE ETHICS COMMITTEE FOR POST GRADUATE RESEARCH |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: N948||Other specified conditions associated with female genital organs and menstrual cycle, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Comparator Agent |
NIL |
No local anaesthetic agent Iis inflitrated after suturing the vault . |
Intervention |
ofInfiltration of 0.25% 10ml of Bupivacaine in the vaginal vault |
Intervention Group A in which Bupivacaine will be inflitrated laparoscopically after suturing the vault.
|
|
Inclusion Criteria
|
Age From |
35.00 Year(s) |
Age To |
60.00 Year(s) |
Gender |
Female |
Details |
1. All patients who needs TLH with or without bilateral salpingo-oophorectomy for benign conditions.
2. Uterine size ≤12weeks of pregnancy
|
|
ExclusionCriteria |
Details |
1. Presence of malignancy
2. Contraindication to any medication which will be used in the study (Bupivacaine, paracetamol)
3. History of chronic PID
4. History of previous multiple surgeries
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
On-site computer system |
Blinding/Masking
|
Participant and Investigator Blinded |
Primary Outcome
|
Outcome |
TimePoints |
Comparison of post operative pain and short term morbidity in both the groups. |
on post operative day 0.
3hours, 6hours, 8 hours 12 and 24 hours |
|
Secondary Outcome
|
Outcome |
TimePoints |
NONE |
NONE |
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
04/05/2020 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
NIL |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
All patients for total
laparoscopic hysterectomy( TLH ) for
benign condition will be recruited from gynaecology OPD at All India Institute
of Medical Sciences, New Delhi.
Study Design: Prospective two arms
double blinded Randomized Control Trial.
Total number of
patients recruited will be– 60
Patients will be
randomly allocated in two groups.
Group I – Intervention group (no. 30) that will receive Bupivacaine
infiltration to vaginal vault after TLH.
Group II – Control group (No. 30) that will not receive Bupivacaine infiltration
in vaginal vault.
The randomization of
participants into their respective group will be allocated using a
computer-generated randomization programme. The allocation cards will be sealed
in sequentially numbered envelope. The principal surgeon will open the
envelopes in the operation theatre prior to surgery. |